Form 8-K - Current report:
SEC Accession No. 0001640334-24-001003
Filing Date
2024-06-21
Accepted
2024-06-21 16:16:48
Documents
17
Period of Report
2024-06-21
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K bmmj_8k.htm   iXBRL 8-K 48267
2 NEWS RELEASE bmmj_ex991.htm EX-99.1 29619
8 bmmj_ex991img2.jpg GRAPHIC 3789
  Complete submission text file 0001640334-24-001003.txt   209497

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA bmmj-20240621.xsd EX-101.SCH 5741
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE bmmj-20240621_lab.xml EX-101.LAB 13685
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bmmj-20240621_cal.xml EX-101.CAL 912
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bmmj-20240621_pre.xml EX-101.PRE 8613
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bmmj-20240621_def.xml EX-101.DEF 2113
20 EXTRACTED XBRL INSTANCE DOCUMENT bmmj_8k_htm.xml XML 3662
Mailing Address 750 - 1095 WEST PENDER STREET VANCOUVER A1 V6E 2M6
Business Address 750 - 1095 WEST PENDER STREET VANCOUVER A1 V6E 2M6 604-376-3567
BODY & MIND INC. (Filer) CIK: 0001715611 (see all company filings)

EIN.: 981319227 | State of Incorp.: NV | Fiscal Year End: 0731
Type: 8-K | Act: 34 | File No.: 000-55940 | Film No.: 241060404
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)